Skip to main content

Wengen Chen, BM, PhD, MSc

Academic Title:

Professor

Primary Appointment:

Diagnostic Radiology and Nuclear Medicine

Secondary Appointment(s):

Radiation Oncology

Location:

UMMC, Gudelski, C252

Phone (Primary):

866-408-6885

Education and Training

BM, Shanghai Medical University (now Fudan University), China

MPH, Shanghai Medical University (now Fudan University), China

PhD,  University of Tokyo, Japan

Postdoc., Columbia University, NY

Internship in Internal Medicine,  St. Peter's University Hospital, New Brunswick, NJ

Residency in Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA

Fellowship in Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA

Biosketch

I received my medical degree from China, and my Ph.D from Japan. I have more than a decade of basic science research experiences in molecular biology of lipid metabolism and atherosclerosis. After finishing my postdoctoral training at Columbia University, I restarted my clinical training, as a nuclear medicine resident and fellow, in the hospital of the University of Pennsylvania. I started my current position in 2009 as an assistant professor, and was promoted to associate professsor in 2014, and to full professor in 2019. I am a full-time board certified nuclear medicine physician, and provide services in general nuclear medicine imaging, PET/CT, and radionuclide therapy.

Research/Clinical Keywords

PET/CT, atherosclerosis, infection

Highlighted Publications

Chen W, Dilsizian V. Diagnosis and Image-Guided Therapy of Cardiac Left Ventricular Assist Device Infections. Seminar Nuclear Medicine, 2020 Dec 3:S0001-2998 (20)30122-7

Chen W, Dilsizian V. Molecular Imaging of Amyloid Deposits in the Heart Allows Early Diagnosis of Cardiac Amyloidosis and the Potential for Monitoring Treatment Response. JACC Cardiovasc Imaging. 2020, Jun;13(6):1348-1352.

Chen W, Dilsizian V. Molecular Imaging of Cardiovascular Device Infection: Targeting the Bacteria or the Host-Pathogen Immune Response? J Nucl Med. 2020, March; 61(3):319-326.

 

Chen W, Dilsizian V. Radioactive Iodine Treatment and Cancer Mortality in Hyperthyroid Patients: Questioning Standard Clinical Practice Requires Indisputable Scientific Data. J Nucl Med. 2019, Nov; 60(11):1502-1503

Chen W, Dilsizian V. Is 18F-Flurodeoxyglucose Positron Emission Tomography/Computed Tomography More Reliable than Clinical Standard Diagnosis for Guiding Patient Management Decisions in Cardiac Implantable Electronic Device Infection? Circ Cardiovasc Imaging. 2019, Jul;12(7):e009453. 

Chen W , Jeudy J, Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR? Curr Cardiol Rep. 2019, Jun 26;21(8):76

Chen W, Dilsizian V. FDG PET/CT for the Diagnosis and Management of Infective Endocarditis: Expert Consensus versus Evidence-Based Practice. J Nucl Cardiol. 2019, Feb; 26(1):313-315.

Kim J, Feller ED, Chen W, Liang Y, Dilsizian V. FDG PET/CT for early detection and localization of left ventricular assist device infection: impact on patient management and outcome. JACC Cardiovasc Imaging. 2019, Apr. 12(4):722-729

Chen W, Sajadi M, Dilsizian V. Merits of FDG PET/CT and Functional Molecular Imaging over Anatomic Imaging with Echocardiography and CT angiography for the Diagnosis of Cardiac Device Infections. JACC Cardiovasc Imaging. 2018, Nov; 11(11):1679-1691.

 

 

Research Interests

Clinical Specialty Details

Awards and Affiliations

Grants and Contracts

In the News

Professional Activity

×